Genomic Health (GHDX) Inactive 10-K2009 FY Annual report

Filed: 15 Mar 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: abstract, ACLU, anamicibrief, antigen, Australian, authoritative, Barrett, Bilski, built, byThe, CancerMpact, Chinese, Circuit, Cleveland, coalition, Codification, cohort, commensurate, country, deficiency, deficient, denominated, distributor, diversification, door, earned, ECOG, endpoint, entitledIn, esophageal, evolution, expertise, fewer, flow, Gastrointestinal, Germany, Gleason, Globocan, grantedcertiorariin, greatest, hearing, Hologic, HR, HTS, IHC, immunohistochemistry, increasingly, ineffective, intercompany, interval, Japanese, lymphovascular, machine, media, microdissected, microsatellite, Middle, mismatch, MMR, mode, MSI, multigene, Myriad, nodal, opposition, overpayment, oxaliplatin, parallelize, penetrate, penetration, percent, preauthorization, precertification, predetermined, predominantly, preliminary, priority, PSA, pursuit, Qiagen, Ratification, recite, reconciliation, ReleaseNo, relocation, salary, sequential, settlement, smaller, Southern, Spain, surveillance, susceptibility, Taiwanese, taxation, territory, testd, theBilski, thirteen, tied, Topic, trace, transformation, triple, uneven, uninformative, Union, unmet, USPTO, wall, weak, web, workflow

Removed: APB, APIC, Bayer, beneficially, Blue, borrow, broader, capitalization, category, CFO, classifying, compare, contractor, conversation, deferral, dialogue, divested, EITF, FAS, FIN, forced, fourth, guideline, Heritage, inform, intense, interrupt, kit, lab, LDT, LifeSeq, month, NHIC, nonexclusive, pool, receiving, released, Shield, simplified, Task, today, traditional, vote

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

GHDX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

STATEMENT OF CHIEF EXECUTIVE OFFICER UNDER 18 U.S.C. § 1350

I, Kimberly J. Popovits, the chief executive officer of Genomic Health, Inc. (the “Company”), certify for the purposes of section 1350 of chapter 63 of title 18 of the United States Code that, to the best of my knowledge,

(i) the Annual Report of the Company on Form 10-K for the period ended December 31, 2009 (the “Report”), fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934, and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


	/s/ Kimberly J. Popovits
	Kimberly J. Popovits.
	Chief Executive Officer
	March 15, 2010